How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Ben Taylor, CFO of Recursion, here with us. Thanks so much for joining us. Sure. Great. And first of all, thanks for having us here, Tommie. This is always a terrific conference and great to be here.

The loop takes agentic AI a step further, by authorizing a swarm of agents to work continuously in the background, endlessly.

The companies at the frontier of artificial intelligence should be ready to slow down, one of the fastest-moving among them says. Anthropic, the maker of the Claude chatbot, has claimed AI systems may ...

Hermes Agent async subagents are now live after Nous Research shipped the async_delegation toolset on June 15, 2026.

What are Fugu and Fugu Ultra, the AI systems through which Japan's Sakana AI is betting on 'One Model To Command Them All' ...

On June 24, 2026, Microsoft’s Digital Crimes Unit (DCU) facilitated the takedown, suspension, and blocking of domains that ...

Everyone is racing to point powerful AI models at drug discovery. A growing camp argues the real prize is the layer beneath the models — the connected biological knowledge they reason over — and that ...

On June 4, 2026, Anthropic published one of the most consequential blog posts in the short history of artificial intelligence. The piece, titled “When AI Builds Itself” and co-authored by Anthropic co ...

FortiBleed targeted 430,000 FortiGate firewalls with sniffers and brute-force pipelines that identified over 110 million ...

Adobe faces persistent new lows, leadership transition upheavals, and intense threats from AI foundation model companies. Find out why ADBE stock is a hold.